Expanded timing includes annual MRD testing during maintenance and after subsequent therapy lines, including following CAR-T, to enable serial assessment rather than single timepoint interpretation.

Chronic lymphocytic leukemia (CLL) is a form of cancer that leads to an atypically high level of lymphocytes within the bone marrow. Tests, such as a bone marrow biopsy, can determine how advanced CLL ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in ...